BDX vs HAE · P/E 34, rev $21.84B vs P/E 35, rev $1.36B
Becton Dickinson and Company (BDX) versus Haemonetics Corporation (HAE) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported HAE revenue for 2025-03-29 was $1.36B. Net income was $167.7M. Revenue was up 4.0% from 2024-03-30 to 2025-03-29. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Not investment advice. Open the BDX and HAE stock pages for the full models.
Not investment advice.